S3V Vascular Technologies is planning to set up a state-of-the-art integrated facility in India.
The company will invest Rs 140 crore to develop the devices in Intervention Cardiology, Neurology, Peripheral and Endovascular treatments. The facility which has received USFDA approval will come up on 15 acre. The project will come either in Andhra Pradesh or in Karnataka.